nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—Salicylic acid—Niacin—atherosclerosis	0.515	1	CrCrCtD
Salicylate-sodium—PTGS2—atherosclerosis	0.311	1	CbGaD
Salicylate-sodium—Distention—Pravastatin—atherosclerosis	0.00348	0.0381	CcSEcCtD
Salicylate-sodium—PTGS2—leg—atherosclerosis	0.00284	0.145	CbGeAlD
Salicylate-sodium—Tracheobronchitis—Pravastatin—atherosclerosis	0.00272	0.0297	CcSEcCtD
Salicylate-sodium—Warmth—Niacin—atherosclerosis	0.00262	0.0287	CcSEcCtD
Salicylate-sodium—PTGS2—hindlimb—atherosclerosis	0.00254	0.13	CbGeAlD
Salicylate-sodium—PTGS2—appendage—atherosclerosis	0.00218	0.111	CbGeAlD
Salicylate-sodium—PTGS1—artery—atherosclerosis	0.00163	0.0831	CbGeAlD
Salicylate-sodium—PTGS2—artery—atherosclerosis	0.00155	0.0794	CbGeAlD
Salicylate-sodium—Upset stomach—Lovastatin—atherosclerosis	0.00148	0.0162	CcSEcCtD
Salicylate-sodium—Upset stomach—Simvastatin—atherosclerosis	0.00139	0.0152	CcSEcCtD
Salicylate-sodium—PTGS1—endothelium—atherosclerosis	0.00137	0.0702	CbGeAlD
Salicylate-sodium—PTGS2—endothelium—atherosclerosis	0.00131	0.0671	CbGeAlD
Salicylate-sodium—PTGS1—blood vessel—atherosclerosis	0.00127	0.0647	CbGeAlD
Salicylate-sodium—Heartburn—Niacin—atherosclerosis	0.00121	0.0132	CcSEcCtD
Salicylate-sodium—PTGS2—blood vessel—atherosclerosis	0.00121	0.0618	CbGeAlD
Salicylate-sodium—Burning sensation—Niacin—atherosclerosis	0.0012	0.0131	CcSEcCtD
Salicylate-sodium—Heartburn—Pravastatin—atherosclerosis	0.00119	0.013	CcSEcCtD
Salicylate-sodium—Tenderness—Lovastatin—atherosclerosis	0.00111	0.0122	CcSEcCtD
Salicylate-sodium—Feeling hot—Niacin—atherosclerosis	0.00106	0.0116	CcSEcCtD
Salicylate-sodium—Necrosis—Niacin—atherosclerosis	0.00106	0.0116	CcSEcCtD
Salicylate-sodium—Tenderness—Simvastatin—atherosclerosis	0.00104	0.0114	CcSEcCtD
Salicylate-sodium—Tingling sensation—Niacin—atherosclerosis	0.00104	0.0113	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—EDNRA—atherosclerosis	0.00097	0.224	CrCbGaD
Salicylate-sodium—Tenderness—Pravastatin—atherosclerosis	0.000941	0.0103	CcSEcCtD
Salicylate-sodium—Renal failure acute—Rosuvastatin—atherosclerosis	0.000901	0.00985	CcSEcCtD
Salicylate-sodium—Hearing impaired—Pravastatin—atherosclerosis	0.000862	0.00943	CcSEcCtD
Salicylate-sodium—Mesalazine—ALOX5—atherosclerosis	0.000827	0.191	CrCbGaD
Salicylate-sodium—Skin exfoliation—Niacin—atherosclerosis	0.000796	0.0087	CcSEcCtD
Salicylate-sodium—Fluid retention—Niacin—atherosclerosis	0.000791	0.00865	CcSEcCtD
Salicylate-sodium—Oesophagitis—Niacin—atherosclerosis	0.000762	0.00833	CcSEcCtD
Salicylate-sodium—Swelling—Simvastatin—atherosclerosis	0.000747	0.00817	CcSEcCtD
Salicylate-sodium—Bronchitis—Rosuvastatin—atherosclerosis	0.000691	0.00756	CcSEcCtD
Salicylate-sodium—Deafness—Pravastatin—atherosclerosis	0.000666	0.00728	CcSEcCtD
Salicylate-sodium—PTGS1—connective tissue—atherosclerosis	0.00065	0.0332	CbGeAlD
Salicylate-sodium—Renal failure acute—Pravastatin—atherosclerosis	0.000645	0.00706	CcSEcCtD
Salicylate-sodium—PTGS2—connective tissue—atherosclerosis	0.000621	0.0317	CbGeAlD
Salicylate-sodium—Abdominal discomfort—Lovastatin—atherosclerosis	0.000584	0.00638	CcSEcCtD
Salicylate-sodium—Hepatitis—Rosuvastatin—atherosclerosis	0.000575	0.00629	CcSEcCtD
Salicylate-sodium—PTGS1—cardiovascular system—atherosclerosis	0.000565	0.0289	CbGeAlD
Salicylate-sodium—Bronchitis—Simvastatin—atherosclerosis	0.000548	0.00599	CcSEcCtD
Salicylate-sodium—Abdominal discomfort—Simvastatin—atherosclerosis	0.000546	0.00597	CcSEcCtD
Salicylate-sodium—PTGS2—cardiovascular system—atherosclerosis	0.00054	0.0276	CbGeAlD
Salicylate-sodium—Mesalazine—MPO—atherosclerosis	0.000533	0.123	CrCbGaD
Salicylate-sodium—Abdominal distension—Niacin—atherosclerosis	0.000527	0.00576	CcSEcCtD
Salicylate-sodium—Dysphagia—Niacin—atherosclerosis	0.000523	0.00572	CcSEcCtD
Salicylate-sodium—Abdominal distension—Pravastatin—atherosclerosis	0.000518	0.00567	CcSEcCtD
Salicylate-sodium—Arrhythmia—Rosuvastatin—atherosclerosis	0.000514	0.00562	CcSEcCtD
Salicylate-sodium—Bronchitis—Niacin—atherosclerosis	0.000503	0.0055	CcSEcCtD
Salicylate-sodium—Sweating increased—Pravastatin—atherosclerosis	0.000502	0.00548	CcSEcCtD
Salicylate-sodium—PTGS1—adipose tissue—atherosclerosis	0.000498	0.0255	CbGeAlD
Salicylate-sodium—Flatulence—Rosuvastatin—atherosclerosis	0.000493	0.00539	CcSEcCtD
Salicylate-sodium—Hepatitis—Lovastatin—atherosclerosis	0.000487	0.00533	CcSEcCtD
Salicylate-sodium—Hepatitis—Ezetimibe—atherosclerosis	0.000478	0.00523	CcSEcCtD
Salicylate-sodium—PTGS2—adipose tissue—atherosclerosis	0.000476	0.0243	CbGeAlD
Salicylate-sodium—Mesalazine—PPARG—atherosclerosis	0.000473	0.109	CrCbGaD
Salicylate-sodium—Weight increased—Pravastatin—atherosclerosis	0.000469	0.00512	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Lovastatin—atherosclerosis	0.000461	0.00504	CcSEcCtD
Salicylate-sodium—Hepatitis—Simvastatin—atherosclerosis	0.000456	0.00499	CcSEcCtD
Salicylate-sodium—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000453	0.00495	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Ezetimibe—atherosclerosis	0.000452	0.00494	CcSEcCtD
Salicylate-sodium—Myocardial infarction—Pravastatin—atherosclerosis	0.00045	0.00492	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Simvastatin—atherosclerosis	0.000431	0.00471	CcSEcCtD
Salicylate-sodium—Hepatitis—Niacin—atherosclerosis	0.000419	0.00458	CcSEcCtD
Salicylate-sodium—Flatulence—Lovastatin—atherosclerosis	0.000418	0.00457	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Niacin—atherosclerosis	0.000417	0.00455	CcSEcCtD
Salicylate-sodium—Erythema—Ezetimibe—atherosclerosis	0.000416	0.00455	CcSEcCtD
Salicylate-sodium—Dysgeusia—Lovastatin—atherosclerosis	0.000416	0.00454	CcSEcCtD
Salicylate-sodium—Hepatitis—Pravastatin—atherosclerosis	0.000412	0.00451	CcSEcCtD
Salicylate-sodium—Confusional state—Rosuvastatin—atherosclerosis	0.000412	0.00451	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Pravastatin—atherosclerosis	0.00041	0.00448	CcSEcCtD
Salicylate-sodium—Flatulence—Ezetimibe—atherosclerosis	0.00041	0.00448	CcSEcCtD
Salicylate-sodium—Infection—Rosuvastatin—atherosclerosis	0.000406	0.00444	CcSEcCtD
Salicylate-sodium—Vision blurred—Lovastatin—atherosclerosis	0.0004	0.00437	CcSEcCtD
Salicylate-sodium—Erythema—Simvastatin—atherosclerosis	0.000397	0.00434	CcSEcCtD
Salicylate-sodium—Flatulence—Simvastatin—atherosclerosis	0.000391	0.00428	CcSEcCtD
Salicylate-sodium—Tinnitus—Niacin—atherosclerosis	0.00039	0.00427	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Pravastatin—atherosclerosis	0.00039	0.00426	CcSEcCtD
Salicylate-sodium—Dysgeusia—Simvastatin—atherosclerosis	0.000389	0.00425	CcSEcCtD
Salicylate-sodium—Tinnitus—Pravastatin—atherosclerosis	0.000384	0.0042	CcSEcCtD
Salicylate-sodium—Vision blurred—Simvastatin—atherosclerosis	0.000374	0.00409	CcSEcCtD
Salicylate-sodium—Arrhythmia—Niacin—atherosclerosis	0.000374	0.00409	CcSEcCtD
Salicylate-sodium—Arrhythmia—Pravastatin—atherosclerosis	0.000368	0.00403	CcSEcCtD
Salicylate-sodium—Palpitations—Ezetimibe—atherosclerosis	0.000368	0.00402	CcSEcCtD
Salicylate-sodium—Paraesthesia—Rosuvastatin—atherosclerosis	0.000367	0.00401	CcSEcCtD
Salicylate-sodium—Erythema—Niacin—atherosclerosis	0.000364	0.00398	CcSEcCtD
Salicylate-sodium—Chest pain—Lovastatin—atherosclerosis	0.000361	0.00395	CcSEcCtD
Salicylate-sodium—Anxiety—Lovastatin—atherosclerosis	0.00036	0.00394	CcSEcCtD
Salicylate-sodium—Dyspepsia—Rosuvastatin—atherosclerosis	0.00036	0.00393	CcSEcCtD
Salicylate-sodium—Flatulence—Niacin—atherosclerosis	0.000359	0.00393	CcSEcCtD
Salicylate-sodium—Chest pain—Ezetimibe—atherosclerosis	0.000354	0.00387	CcSEcCtD
Salicylate-sodium—Flatulence—Pravastatin—atherosclerosis	0.000354	0.00387	CcSEcCtD
Salicylate-sodium—Dysgeusia—Pravastatin—atherosclerosis	0.000351	0.00384	CcSEcCtD
Salicylate-sodium—Pain—Rosuvastatin—atherosclerosis	0.000349	0.00382	CcSEcCtD
Salicylate-sodium—Constipation—Rosuvastatin—atherosclerosis	0.000349	0.00382	CcSEcCtD
Salicylate-sodium—Confusional state—Lovastatin—atherosclerosis	0.000349	0.00382	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Lovastatin—atherosclerosis	0.000346	0.00379	CcSEcCtD
Salicylate-sodium—Infection—Lovastatin—atherosclerosis	0.000344	0.00376	CcSEcCtD
Salicylate-sodium—Vision blurred—Niacin—atherosclerosis	0.000343	0.00376	CcSEcCtD
Salicylate-sodium—Confusional state—Ezetimibe—atherosclerosis	0.000343	0.00374	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00034	0.00371	CcSEcCtD
Salicylate-sodium—Vision blurred—Pravastatin—atherosclerosis	0.000338	0.0037	CcSEcCtD
Salicylate-sodium—Chest pain—Simvastatin—atherosclerosis	0.000338	0.00369	CcSEcCtD
Salicylate-sodium—Infection—Ezetimibe—atherosclerosis	0.000337	0.00369	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000337	0.00368	CcSEcCtD
Salicylate-sodium—Anxiety—Simvastatin—atherosclerosis	0.000337	0.00368	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000334	0.00365	CcSEcCtD
Salicylate-sodium—PTGS2—liver—atherosclerosis	0.000334	0.0171	CbGeAlD
Salicylate-sodium—Anorexia—Lovastatin—atherosclerosis	0.00033	0.00361	CcSEcCtD
Salicylate-sodium—Syncope—Niacin—atherosclerosis	0.000327	0.00357	CcSEcCtD
Salicylate-sodium—Confusional state—Simvastatin—atherosclerosis	0.000327	0.00357	CcSEcCtD
Salicylate-sodium—Urticaria—Rosuvastatin—atherosclerosis	0.000325	0.00355	CcSEcCtD
Salicylate-sodium—Oedema—Simvastatin—atherosclerosis	0.000324	0.00354	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Simvastatin—atherosclerosis	0.000324	0.00354	CcSEcCtD
Salicylate-sodium—Abdominal pain—Rosuvastatin—atherosclerosis	0.000323	0.00353	CcSEcCtD
Salicylate-sodium—Palpitations—Niacin—atherosclerosis	0.000322	0.00352	CcSEcCtD
Salicylate-sodium—Infection—Simvastatin—atherosclerosis	0.000322	0.00352	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Niacin—atherosclerosis	0.00032	0.0035	CcSEcCtD
Salicylate-sodium—Paraesthesia—Lovastatin—atherosclerosis	0.000311	0.0034	CcSEcCtD
Salicylate-sodium—Anorexia—Simvastatin—atherosclerosis	0.000309	0.00338	CcSEcCtD
Salicylate-sodium—Dyspnoea—Lovastatin—atherosclerosis	0.000309	0.00338	CcSEcCtD
Salicylate-sodium—Chest pain—Pravastatin—atherosclerosis	0.000306	0.00334	CcSEcCtD
Salicylate-sodium—Paraesthesia—Ezetimibe—atherosclerosis	0.000305	0.00333	CcSEcCtD
Salicylate-sodium—Dyspepsia—Lovastatin—atherosclerosis	0.000305	0.00333	CcSEcCtD
Salicylate-sodium—Anxiety—Pravastatin—atherosclerosis	0.000304	0.00333	CcSEcCtD
Salicylate-sodium—Dyspnoea—Ezetimibe—atherosclerosis	0.000303	0.00331	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000301	0.00329	CcSEcCtD
Salicylate-sodium—Decreased appetite—Lovastatin—atherosclerosis	0.000301	0.00329	CcSEcCtD
Salicylate-sodium—Dyspepsia—Ezetimibe—atherosclerosis	0.000299	0.00327	CcSEcCtD
Salicylate-sodium—Fatigue—Lovastatin—atherosclerosis	0.000299	0.00326	CcSEcCtD
Salicylate-sodium—Oedema—Niacin—atherosclerosis	0.000297	0.00325	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Niacin—atherosclerosis	0.000297	0.00325	CcSEcCtD
Salicylate-sodium—Constipation—Lovastatin—atherosclerosis	0.000296	0.00324	CcSEcCtD
Salicylate-sodium—Pain—Lovastatin—atherosclerosis	0.000296	0.00324	CcSEcCtD
Salicylate-sodium—Confusional state—Pravastatin—atherosclerosis	0.000295	0.00323	CcSEcCtD
Salicylate-sodium—Decreased appetite—Ezetimibe—atherosclerosis	0.000295	0.00323	CcSEcCtD
Salicylate-sodium—Asthenia—Rosuvastatin—atherosclerosis	0.000293	0.00321	CcSEcCtD
Salicylate-sodium—Oedema—Pravastatin—atherosclerosis	0.000293	0.0032	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Pravastatin—atherosclerosis	0.000293	0.0032	CcSEcCtD
Salicylate-sodium—Fatigue—Ezetimibe—atherosclerosis	0.000293	0.0032	CcSEcCtD
Salicylate-sodium—Shock—Niacin—atherosclerosis	0.000293	0.0032	CcSEcCtD
Salicylate-sodium—Infection—Pravastatin—atherosclerosis	0.000291	0.00318	CcSEcCtD
Salicylate-sodium—Paraesthesia—Simvastatin—atherosclerosis	0.000291	0.00318	CcSEcCtD
Salicylate-sodium—Pain—Ezetimibe—atherosclerosis	0.00029	0.00318	CcSEcCtD
Salicylate-sodium—Constipation—Ezetimibe—atherosclerosis	0.00029	0.00318	CcSEcCtD
Salicylate-sodium—Tachycardia—Niacin—atherosclerosis	0.00029	0.00317	CcSEcCtD
Salicylate-sodium—Pruritus—Rosuvastatin—atherosclerosis	0.000289	0.00316	CcSEcCtD
Salicylate-sodium—Dyspnoea—Simvastatin—atherosclerosis	0.000289	0.00316	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Niacin—atherosclerosis	0.000288	0.00314	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Lovastatin—atherosclerosis	0.000285	0.00312	CcSEcCtD
Salicylate-sodium—Dyspepsia—Simvastatin—atherosclerosis	0.000285	0.00312	CcSEcCtD
Salicylate-sodium—Anorexia—Niacin—atherosclerosis	0.000284	0.0031	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000283	0.0031	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Pravastatin—atherosclerosis	0.000283	0.0031	CcSEcCtD
Salicylate-sodium—Decreased appetite—Simvastatin—atherosclerosis	0.000282	0.00308	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Ezetimibe—atherosclerosis	0.00028	0.00306	CcSEcCtD
Salicylate-sodium—Diarrhoea—Rosuvastatin—atherosclerosis	0.00028	0.00306	CcSEcCtD
Salicylate-sodium—Fatigue—Simvastatin—atherosclerosis	0.000279	0.00305	CcSEcCtD
Salicylate-sodium—Anorexia—Pravastatin—atherosclerosis	0.000279	0.00305	CcSEcCtD
Salicylate-sodium—Hypotension—Niacin—atherosclerosis	0.000278	0.00304	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000278	0.00304	CcSEcCtD
Salicylate-sodium—Pain—Simvastatin—atherosclerosis	0.000277	0.00303	CcSEcCtD
Salicylate-sodium—Constipation—Simvastatin—atherosclerosis	0.000277	0.00303	CcSEcCtD
Salicylate-sodium—Urticaria—Lovastatin—atherosclerosis	0.000275	0.00301	CcSEcCtD
Salicylate-sodium—Body temperature increased—Lovastatin—atherosclerosis	0.000274	0.00299	CcSEcCtD
Salicylate-sodium—Abdominal pain—Lovastatin—atherosclerosis	0.000274	0.00299	CcSEcCtD
Salicylate-sodium—Magnesium salicylate—PTGS2—atherosclerosis	0.000271	0.0624	CrCbGaD
Salicylate-sodium—Dizziness—Rosuvastatin—atherosclerosis	0.00027	0.00295	CcSEcCtD
Salicylate-sodium—Urticaria—Ezetimibe—atherosclerosis	0.00027	0.00295	CcSEcCtD
Salicylate-sodium—Body temperature increased—Ezetimibe—atherosclerosis	0.000269	0.00294	CcSEcCtD
Salicylate-sodium—Abdominal pain—Ezetimibe—atherosclerosis	0.000269	0.00294	CcSEcCtD
Salicylate-sodium—Paraesthesia—Niacin—atherosclerosis	0.000267	0.00292	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Simvastatin—atherosclerosis	0.000267	0.00292	CcSEcCtD
Salicylate-sodium—Dyspnoea—Niacin—atherosclerosis	0.000265	0.0029	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000265	0.0029	CcSEcCtD
Salicylate-sodium—Somnolence—Niacin—atherosclerosis	0.000264	0.00289	CcSEcCtD
Salicylate-sodium—Paraesthesia—Pravastatin—atherosclerosis	0.000263	0.00288	CcSEcCtD
Salicylate-sodium—Dyspepsia—Niacin—atherosclerosis	0.000262	0.00286	CcSEcCtD
Salicylate-sodium—Dyspnoea—Pravastatin—atherosclerosis	0.000261	0.00285	CcSEcCtD
Salicylate-sodium—Decreased appetite—Niacin—atherosclerosis	0.000259	0.00283	CcSEcCtD
Salicylate-sodium—Dyspepsia—Pravastatin—atherosclerosis	0.000258	0.00282	CcSEcCtD
Salicylate-sodium—Rash—Rosuvastatin—atherosclerosis	0.000258	0.00282	CcSEcCtD
Salicylate-sodium—Dermatitis—Rosuvastatin—atherosclerosis	0.000257	0.00281	CcSEcCtD
Salicylate-sodium—Urticaria—Simvastatin—atherosclerosis	0.000257	0.00281	CcSEcCtD
Salicylate-sodium—Abdominal pain—Simvastatin—atherosclerosis	0.000256	0.0028	CcSEcCtD
Salicylate-sodium—Body temperature increased—Simvastatin—atherosclerosis	0.000256	0.0028	CcSEcCtD
Salicylate-sodium—Headache—Rosuvastatin—atherosclerosis	0.000256	0.0028	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Lovastatin—atherosclerosis	0.000255	0.00279	CcSEcCtD
Salicylate-sodium—Decreased appetite—Pravastatin—atherosclerosis	0.000255	0.00278	CcSEcCtD
Salicylate-sodium—Pain—Niacin—atherosclerosis	0.000254	0.00278	CcSEcCtD
Salicylate-sodium—Fatigue—Pravastatin—atherosclerosis	0.000252	0.00276	CcSEcCtD
Salicylate-sodium—Constipation—Pravastatin—atherosclerosis	0.00025	0.00274	CcSEcCtD
Salicylate-sodium—Pain—Pravastatin—atherosclerosis	0.00025	0.00274	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Ezetimibe—atherosclerosis	0.00025	0.00274	CcSEcCtD
Salicylate-sodium—Asthenia—Lovastatin—atherosclerosis	0.000248	0.00272	CcSEcCtD
Salicylate-sodium—Pruritus—Lovastatin—atherosclerosis	0.000245	0.00268	CcSEcCtD
Salicylate-sodium—Asthenia—Ezetimibe—atherosclerosis	0.000244	0.00266	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Niacin—atherosclerosis	0.000243	0.00266	CcSEcCtD
Salicylate-sodium—Nausea—Rosuvastatin—atherosclerosis	0.000243	0.00265	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Pravastatin—atherosclerosis	0.000241	0.00264	CcSEcCtD
Salicylate-sodium—Magnesium salicylate—ALB—atherosclerosis	0.000241	0.0556	CrCbGaD
Salicylate-sodium—Pruritus—Ezetimibe—atherosclerosis	0.00024	0.00263	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000239	0.00262	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Simvastatin—atherosclerosis	0.000239	0.00261	CcSEcCtD
Salicylate-sodium—Diarrhoea—Lovastatin—atherosclerosis	0.000237	0.00259	CcSEcCtD
Salicylate-sodium—Urticaria—Niacin—atherosclerosis	0.000236	0.00258	CcSEcCtD
Salicylate-sodium—Abdominal pain—Niacin—atherosclerosis	0.000235	0.00257	CcSEcCtD
Salicylate-sodium—Body temperature increased—Niacin—atherosclerosis	0.000235	0.00257	CcSEcCtD
Salicylate-sodium—Urticaria—Pravastatin—atherosclerosis	0.000233	0.00254	CcSEcCtD
Salicylate-sodium—Asthenia—Simvastatin—atherosclerosis	0.000232	0.00254	CcSEcCtD
Salicylate-sodium—Diarrhoea—Ezetimibe—atherosclerosis	0.000232	0.00254	CcSEcCtD
Salicylate-sodium—Body temperature increased—Pravastatin—atherosclerosis	0.000232	0.00253	CcSEcCtD
Salicylate-sodium—Abdominal pain—Pravastatin—atherosclerosis	0.000232	0.00253	CcSEcCtD
Salicylate-sodium—Salsalate—PTGS2—atherosclerosis	0.00023	0.0531	CrCbGaD
Salicylate-sodium—Pruritus—Simvastatin—atherosclerosis	0.000229	0.00251	CcSEcCtD
Salicylate-sodium—Dizziness—Lovastatin—atherosclerosis	0.000229	0.0025	CcSEcCtD
Salicylate-sodium—Dizziness—Ezetimibe—atherosclerosis	0.000225	0.00246	CcSEcCtD
Salicylate-sodium—Diarrhoea—Simvastatin—atherosclerosis	0.000222	0.00242	CcSEcCtD
Salicylate-sodium—Vomiting—Lovastatin—atherosclerosis	0.00022	0.00241	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Niacin—atherosclerosis	0.000219	0.0024	CcSEcCtD
Salicylate-sodium—Rash—Lovastatin—atherosclerosis	0.000218	0.00239	CcSEcCtD
Salicylate-sodium—Dermatitis—Lovastatin—atherosclerosis	0.000218	0.00239	CcSEcCtD
Salicylate-sodium—Headache—Lovastatin—atherosclerosis	0.000217	0.00237	CcSEcCtD
Salicylate-sodium—Vomiting—Ezetimibe—atherosclerosis	0.000216	0.00236	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Pravastatin—atherosclerosis	0.000216	0.00236	CcSEcCtD
Salicylate-sodium—Dizziness—Simvastatin—atherosclerosis	0.000214	0.00234	CcSEcCtD
Salicylate-sodium—Rash—Ezetimibe—atherosclerosis	0.000214	0.00234	CcSEcCtD
Salicylate-sodium—Dermatitis—Ezetimibe—atherosclerosis	0.000214	0.00234	CcSEcCtD
Salicylate-sodium—Asthenia—Niacin—atherosclerosis	0.000213	0.00233	CcSEcCtD
Salicylate-sodium—Headache—Ezetimibe—atherosclerosis	0.000213	0.00233	CcSEcCtD
Salicylate-sodium—Pruritus—Niacin—atherosclerosis	0.00021	0.0023	CcSEcCtD
Salicylate-sodium—Asthenia—Pravastatin—atherosclerosis	0.00021	0.0023	CcSEcCtD
Salicylate-sodium—Pruritus—Pravastatin—atherosclerosis	0.000207	0.00227	CcSEcCtD
Salicylate-sodium—Vomiting—Simvastatin—atherosclerosis	0.000206	0.00225	CcSEcCtD
Salicylate-sodium—Nausea—Lovastatin—atherosclerosis	0.000206	0.00225	CcSEcCtD
Salicylate-sodium—Rash—Simvastatin—atherosclerosis	0.000204	0.00223	CcSEcCtD
Salicylate-sodium—Dermatitis—Simvastatin—atherosclerosis	0.000204	0.00223	CcSEcCtD
Salicylate-sodium—Diarrhoea—Niacin—atherosclerosis	0.000204	0.00223	CcSEcCtD
Salicylate-sodium—Headache—Simvastatin—atherosclerosis	0.000203	0.00222	CcSEcCtD
Salicylate-sodium—Nausea—Ezetimibe—atherosclerosis	0.000202	0.00221	CcSEcCtD
Salicylate-sodium—Diarrhoea—Pravastatin—atherosclerosis	0.0002	0.00219	CcSEcCtD
Salicylate-sodium—Mesalazine—PTGS2—atherosclerosis	0.0002	0.0461	CrCbGaD
Salicylate-sodium—Dizziness—Niacin—atherosclerosis	0.000197	0.00215	CcSEcCtD
Salicylate-sodium—Dizziness—Pravastatin—atherosclerosis	0.000194	0.00212	CcSEcCtD
Salicylate-sodium—Nausea—Simvastatin—atherosclerosis	0.000192	0.0021	CcSEcCtD
Salicylate-sodium—Vomiting—Niacin—atherosclerosis	0.000189	0.00207	CcSEcCtD
Salicylate-sodium—Rash—Niacin—atherosclerosis	0.000188	0.00205	CcSEcCtD
Salicylate-sodium—Dermatitis—Niacin—atherosclerosis	0.000187	0.00205	CcSEcCtD
Salicylate-sodium—Headache—Niacin—atherosclerosis	0.000186	0.00204	CcSEcCtD
Salicylate-sodium—Vomiting—Pravastatin—atherosclerosis	0.000186	0.00204	CcSEcCtD
Salicylate-sodium—Rash—Pravastatin—atherosclerosis	0.000185	0.00202	CcSEcCtD
Salicylate-sodium—Dermatitis—Pravastatin—atherosclerosis	0.000184	0.00202	CcSEcCtD
Salicylate-sodium—Headache—Pravastatin—atherosclerosis	0.000183	0.00201	CcSEcCtD
Salicylate-sodium—Nausea—Niacin—atherosclerosis	0.000177	0.00193	CcSEcCtD
Salicylate-sodium—Nausea—Pravastatin—atherosclerosis	0.000174	0.0019	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—PTGS2—atherosclerosis	0.000172	0.0396	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—ALB—atherosclerosis	0.000153	0.0353	CrCbGaD
Salicylate-sodium—Salicylic acid—PTGS2—atherosclerosis	0.000142	0.0326	CrCbGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.00013	0.00221	CbGpPWpGaD
Salicylate-sodium—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—atherosclerosis	0.000126	0.00215	CbGpPWpGaD
Salicylate-sodium—Salicylic acid—ALB—atherosclerosis	0.000126	0.0291	CrCbGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—INS—atherosclerosis	0.000126	0.00213	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—MTHFR—atherosclerosis	0.000125	0.00213	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.000124	0.00211	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—CCL2—atherosclerosis	0.000123	0.0021	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—atherosclerosis	0.000122	0.00207	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—CRP—atherosclerosis	0.000119	0.00202	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.000117	0.00198	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—APOA1—atherosclerosis	0.000115	0.00196	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—SERPINE1—atherosclerosis	0.000115	0.00196	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—ALB—atherosclerosis	0.000115	0.00195	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—F2—atherosclerosis	0.00011	0.00187	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—ICAM1—atherosclerosis	0.00011	0.00186	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000108	0.00183	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000108	0.00183	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000107	0.00182	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.000106	0.0018	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IFNG—atherosclerosis	0.000105	0.00178	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—GSTM1—atherosclerosis	0.000104	0.00177	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000101	0.00171	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000101	0.00171	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—PTGS2—atherosclerosis	0.000101	0.00171	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—INS—atherosclerosis	9.96e-05	0.00169	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	9.89e-05	0.00168	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	9.88e-05	0.00168	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—CCL2—atherosclerosis	9.8e-05	0.00166	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	9.72e-05	0.00165	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IL1B—atherosclerosis	9.37e-05	0.00159	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—LEP—atherosclerosis	9.22e-05	0.00157	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—SERPINE1—atherosclerosis	9.15e-05	0.00155	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—ALB—atherosclerosis	9.13e-05	0.00155	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	9.07e-05	0.00154	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TLR4—atherosclerosis	9.04e-05	0.00153	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	8.98e-05	0.00152	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—NFKB1—atherosclerosis	8.74e-05	0.00148	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—ICAM1—atherosclerosis	8.66e-05	0.00147	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—NOS2—atherosclerosis	8.6e-05	0.00146	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	8.51e-05	0.00144	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	8.51e-05	0.00144	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	8.51e-05	0.00144	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	8.51e-05	0.00144	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	8.51e-05	0.00144	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atherosclerosis	8.48e-05	0.00144	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	8.41e-05	0.00143	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IFNG—atherosclerosis	8.34e-05	0.00141	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	8.12e-05	0.00138	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	8e-05	0.00136	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	8e-05	0.00136	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	7.95e-05	0.00135	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	7.85e-05	0.00133	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	7.79e-05	0.00132	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CCL2—atherosclerosis	7.75e-05	0.00132	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	7.71e-05	0.00131	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	7.5e-05	0.00127	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IL1B—atherosclerosis	7.44e-05	0.00126	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—LDLRAP1—atherosclerosis	7.41e-05	0.00126	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	7.24e-05	0.00123	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	7.13e-05	0.00121	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	7.09e-05	0.0012	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PLTP—atherosclerosis	6.96e-05	0.00118	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—NFKB1—atherosclerosis	6.94e-05	0.00118	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—TNF—atherosclerosis	6.8e-05	0.00115	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	6.76e-05	0.00115	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	6.76e-05	0.00115	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	6.76e-05	0.00115	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	6.76e-05	0.00115	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	6.68e-05	0.00113	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IFNG—atherosclerosis	6.59e-05	0.00112	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	6.45e-05	0.00109	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	6.45e-05	0.00109	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	6.41e-05	0.00109	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	6.37e-05	0.00108	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	6.23e-05	0.00106	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	6.18e-05	0.00105	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—CXCL8—atherosclerosis	6.13e-05	0.00104	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—LTA4H—atherosclerosis	6.04e-05	0.00102	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCG8—atherosclerosis	6.04e-05	0.00102	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	5.99e-05	0.00102	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	5.96e-05	0.00101	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	5.95e-05	0.00101	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL1B—atherosclerosis	5.88e-05	0.000998	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—LDLRAP1—atherosclerosis	5.88e-05	0.000998	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	5.75e-05	0.000975	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	5.63e-05	0.000955	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MMP9—atherosclerosis	5.54e-05	0.000941	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PLTP—atherosclerosis	5.53e-05	0.000938	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IL6—atherosclerosis	5.48e-05	0.000931	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—TNF—atherosclerosis	5.4e-05	0.000916	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	5.18e-05	0.00088	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	5.12e-05	0.000869	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	5.09e-05	0.000864	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	5.06e-05	0.000859	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	5.02e-05	0.000852	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	4.94e-05	0.000839	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—LTA4H—atherosclerosis	4.79e-05	0.000813	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCG8—atherosclerosis	4.79e-05	0.000813	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCG1—atherosclerosis	4.77e-05	0.00081	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	4.73e-05	0.000803	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—MAPK3—atherosclerosis	4.71e-05	0.000799	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TGFB1—atherosclerosis	4.57e-05	0.000775	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—FABP4—atherosclerosis	4.49e-05	0.000762	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—LCAT—atherosclerosis	4.49e-05	0.000762	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	4.47e-05	0.000758	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—APOA4—atherosclerosis	4.4e-05	0.000748	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IL6—atherosclerosis	4.35e-05	0.000739	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP7A1—atherosclerosis	4.33e-05	0.000734	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TNF—atherosclerosis	4.27e-05	0.000724	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—APOA4—atherosclerosis	4.18e-05	0.000709	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	4.12e-05	0.0007	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP27A1—atherosclerosis	4e-05	0.000679	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.98e-05	0.000676	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.94e-05	0.000668	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.84e-05	0.000652	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALOX15—atherosclerosis	3.79e-05	0.000643	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALOX5AP—atherosclerosis	3.79e-05	0.000643	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PLA2G2A—atherosclerosis	3.79e-05	0.000643	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—APOA2—atherosclerosis	3.79e-05	0.000643	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCG1—atherosclerosis	3.79e-05	0.000643	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCG5—atherosclerosis	3.75e-05	0.000636	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	3.74e-05	0.000635	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	3.73e-05	0.000633	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	3.67e-05	0.000622	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—LPA—atherosclerosis	3.62e-05	0.000614	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—APOA2—atherosclerosis	3.59e-05	0.00061	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—LCAT—atherosclerosis	3.56e-05	0.000605	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—FABP4—atherosclerosis	3.56e-05	0.000605	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—BGN—atherosclerosis	3.5e-05	0.000595	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—APOA4—atherosclerosis	3.5e-05	0.000593	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.48e-05	0.00059	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—APOA5—atherosclerosis	3.47e-05	0.000589	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL6—atherosclerosis	3.44e-05	0.000584	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP7A1—atherosclerosis	3.44e-05	0.000583	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	3.39e-05	0.000575	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.37e-05	0.000572	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PLA2G1B—atherosclerosis	3.34e-05	0.000567	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—BGN—atherosclerosis	3.32e-05	0.000564	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.3e-05	0.00056	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	3.27e-05	0.000556	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.27e-05	0.000555	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.26e-05	0.000554	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALOX5—atherosclerosis	3.22e-05	0.000547	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	3.2e-05	0.000544	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP27A1—atherosclerosis	3.18e-05	0.000539	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	3.13e-05	0.00053	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	3.11e-05	0.000527	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	3.05e-05	0.000518	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—APOA2—atherosclerosis	3.01e-05	0.000511	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PLA2G2A—atherosclerosis	3.01e-05	0.000511	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALOX5AP—atherosclerosis	3.01e-05	0.000511	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALOX15—atherosclerosis	3.01e-05	0.000511	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.98e-05	0.000505	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCG5—atherosclerosis	2.97e-05	0.000505	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.97e-05	0.000504	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	2.9e-05	0.000493	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CST3—atherosclerosis	2.89e-05	0.000491	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NAMPT—atherosclerosis	2.89e-05	0.000491	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.87e-05	0.000488	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—LIPC—atherosclerosis	2.87e-05	0.000488	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—LPA—atherosclerosis	2.87e-05	0.000487	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—APOC3—atherosclerosis	2.86e-05	0.000485	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—LDLR—atherosclerosis	2.84e-05	0.000482	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—BGN—atherosclerosis	2.78e-05	0.000472	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CETP—atherosclerosis	2.77e-05	0.00047	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.76e-05	0.000469	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—APOA5—atherosclerosis	2.75e-05	0.000467	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NAMPT—atherosclerosis	2.74e-05	0.000465	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—APOC3—atherosclerosis	2.71e-05	0.000459	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—LDLR—atherosclerosis	2.69e-05	0.000457	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.67e-05	0.000454	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SCARB1—atherosclerosis	2.65e-05	0.000451	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PLA2G1B—atherosclerosis	2.65e-05	0.00045	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.62e-05	0.000445	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HSPA1B—atherosclerosis	2.6e-05	0.000441	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.6e-05	0.000441	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.59e-05	0.00044	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.58e-05	0.000439	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALOX5—atherosclerosis	2.56e-05	0.000434	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NCF1—atherosclerosis	2.52e-05	0.000427	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HMGCR—atherosclerosis	2.51e-05	0.000425	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CYBA—atherosclerosis	2.37e-05	0.000402	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	2.36e-05	0.000401	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PARP1—atherosclerosis	2.32e-05	0.000393	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NAMPT—atherosclerosis	2.3e-05	0.00039	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	2.28e-05	0.000387	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—LIPC—atherosclerosis	2.28e-05	0.000387	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—APOC3—atherosclerosis	2.27e-05	0.000385	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.26e-05	0.000384	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—LDLR—atherosclerosis	2.25e-05	0.000382	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCA1—atherosclerosis	2.23e-05	0.000379	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CETP—atherosclerosis	2.2e-05	0.000373	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	2.16e-05	0.000367	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SCARB1—atherosclerosis	2.11e-05	0.000358	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.05e-05	0.000348	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HMGCR—atherosclerosis	1.99e-05	0.000338	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HMOX1—atherosclerosis	1.92e-05	0.000325	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—APOB—atherosclerosis	1.84e-05	0.000312	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTM1—atherosclerosis	1.79e-05	0.000303	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCA1—atherosclerosis	1.77e-05	0.000301	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—LPL—atherosclerosis	1.75e-05	0.000298	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—APOB—atherosclerosis	1.74e-05	0.000295	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GPX1—atherosclerosis	1.71e-05	0.00029	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CD36—atherosclerosis	1.67e-05	0.000283	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—LPL—atherosclerosis	1.66e-05	0.000282	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PRKCG—atherosclerosis	1.62e-05	0.000274	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—MTHFR—atherosclerosis	1.58e-05	0.000268	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PPARA—atherosclerosis	1.55e-05	0.000263	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HMOX1—atherosclerosis	1.52e-05	0.000258	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—AGT—atherosclerosis	1.5e-05	0.000255	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MTHFR—atherosclerosis	1.5e-05	0.000254	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—APOE—atherosclerosis	1.47e-05	0.000249	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—APOB—atherosclerosis	1.46e-05	0.000247	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PDGFB—atherosclerosis	1.46e-05	0.000247	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CAV1—atherosclerosis	1.46e-05	0.000247	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—APOA1—atherosclerosis	1.45e-05	0.000247	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTM1—atherosclerosis	1.42e-05	0.000241	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—APOE—atherosclerosis	1.39e-05	0.000236	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—LPL—atherosclerosis	1.39e-05	0.000236	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CAV1—atherosclerosis	1.38e-05	0.000234	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—APOA1—atherosclerosis	1.38e-05	0.000234	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GPX1—atherosclerosis	1.36e-05	0.00023	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CG—atherosclerosis	1.33e-05	0.000225	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CD36—atherosclerosis	1.32e-05	0.000224	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NOS2—atherosclerosis	1.3e-05	0.00022	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PPARG—atherosclerosis	1.28e-05	0.000217	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—INS—atherosclerosis	1.26e-05	0.000213	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—MTHFR—atherosclerosis	1.25e-05	0.000213	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PPARA—atherosclerosis	1.23e-05	0.000209	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—AGT—atherosclerosis	1.19e-05	0.000202	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—INS—atherosclerosis	1.19e-05	0.000202	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—APOE—atherosclerosis	1.17e-05	0.000198	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CAV1—atherosclerosis	1.16e-05	0.000196	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—APOA1—atherosclerosis	1.15e-05	0.000196	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ALB—atherosclerosis	1.15e-05	0.000195	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NOS3—atherosclerosis	1.1e-05	0.000187	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SERPINE1—atherosclerosis	1.09e-05	0.000186	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CG—atherosclerosis	1.05e-05	0.000179	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NOS3—atherosclerosis	1.04e-05	0.000177	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PPARG—atherosclerosis	1.02e-05	0.000172	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PTGS2—atherosclerosis	1.01e-05	0.000171	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—INS—atherosclerosis	9.97e-06	0.000169	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ALB—atherosclerosis	9.14e-06	0.000155	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NOS3—atherosclerosis	8.74e-06	0.000148	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—STAT3—atherosclerosis	7.45e-06	0.000126	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MAPK3—atherosclerosis	7.11e-06	0.000121	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TGFB1—atherosclerosis	6.9e-06	0.000117	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IL6—atherosclerosis	5.2e-06	8.83e-05	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—AKT1—atherosclerosis	5.06e-06	8.59e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AKT1—atherosclerosis	4.8e-06	8.14e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—AKT1—atherosclerosis	4.02e-06	6.82e-05	CbGpPWpGaD
